CompletedNot Applicable

Besifloxacin in Bacterial Keratitis

Canada32 participantsStarted 2015-09

Plain-language summary

This is a study comparing a new treatment for bacterial keratitis (also known as corneal ulcers) with the current standard of care. It is a randomized trial, and the investigators plan to test whether besifloxacin (a new antibiotic) in comparison to the current standard of treatment, fortified antibiotic drops (cefazolin and tobramycin).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Provide signed and dated informed consent form * Willing to comply with all study procedures and be available for the duration of the study * Male or female, aged 18 or older * Clinically diagnosed bacterial keratitis, with any size ulcer \> 1mm. Exclusion Criteria: * • Previously treated for current episode of bacterial keratitis with an antibiotic drop * Corneal Ulcers \<1mm * Known allergic reaction to components of the study products

What they're measuring

Time to microbial sterilization of the infected cornea

Timeframe: 2-14 days

Trial details

NCT IDNCT02497365

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06

View on ClinicalTrials.gov More Bacterial Keratitis trials